GE HealthCare’s SIGNA MRI Portfolio Granted FDA Clearance

GE HealthCare’s SIGNA MRI Portfolio Granted FDA Clearance

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations…

Continue Reading
5 Must-Read Analyst Questions From GE HealthCare’s Q4 Earnings Call

5 Must-Read Analyst Questions From GE HealthCare’s Q4 Earnings Call

GE HealthCare’s fourth quarter saw positive momentum, with the company surpassing Wall Street’s revenue and non-GAAP…

Continue Reading
GE HealthCare’s New ECG And AI Imaging Tools Reshape Growth Story

GE HealthCare’s New ECG And AI Imaging Tools Reshape Growth Story

Get insights on thousands of stocks from the global community of over 7 million individual investors…

Continue Reading
CEO of Memorial Health talks about healthcare’s future

CEO of Memorial Health talks about healthcare’s future

Now rural and suburban areas will see more ways to gain better access to the specific…

Continue Reading
GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark

GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug…

Continue Reading
GE HealthCare’s Allia Moveo gains FDA and CE mark approvals

GE HealthCare’s Allia Moveo gains FDA and CE mark approvals

GE HealthCare’s Allia Moveo system GE HealthCare has announced that its Allia Moveo image-guidance platform has…

Continue Reading